Lazar David E.
CIK 0001932843
PresidentDirector10% Owner
Filings
30
Latest May 1, 2026
Issuers covered
11
Showing
30 of 30
Page 1
Track record
3 of 11 open-market trades scored (27% price coverage) - 8 issuers without price data. Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 3 | 100% | +19.3% | +18.2% | +33.5% | +6.3% |
| 90 days | 3 | 100% | +93.7% | +85.4% | +127.3% | +68.4% |
| 180 days | 3 | 100% | +452.3% | +90.2% | +1177.3% | +89.5% |
| 365 days | 2 | 100% | +626.6% | +626.6% | +1154.5% | +98.7% |
Issuers
Companies where Lazar David E. has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| OPGN | Opgen Inc | 6 | Aug 1, 2024 |
| MINM | Minim, Inc. | 5 | Mar 10, 2025 |
| TTNP | Titan Pharmaceuticals Inc | 4 | Jul 31, 2023 |
| CYCC | Cyclacel Pharmaceuticals, Inc. | 3 | Aug 4, 2025 |
| KALA | Kala Pharmaceuticals, Inc. | 2 | Dec 22, 2025 |
| LQR | Lqr House Inc. | 2 | Apr 7, 2025 |
| MYNZ | Mainz Biomed N.V. | 2 | Apr 28, 2026 |
| NBY | Novabay Pharmaceuticals, Inc. | 2 | Jan 29, 2026 |
| SOWG | Sow Good Inc. | 2 | Apr 2, 2026 |
| ATER | Aterian, Inc. | 1 | May 1, 2026 |
| INDP | Indaptus Therapeutics, Inc. | 1 | Mar 24, 2026 |
All filings
30 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|